In this article, we described the development in the field of allergy as described by Clinical and Experimental Allergy in 2017. Experimental models of allergic disease, basic mechanisms, clinical mechanisms, allergens, asthma and rhinitis and clinical allergy are all covered.
1 | ASTHMA AND RHINITIS
| Underlying mechanisms of asthma
Although novel technologies that allow unbiased detection of biomarkers for diseases are being used increasingly their clinical application remains uncertain. 1 Omics approaches are high-throughput technologies that provide a cross-sectional analysis of biological systems including genomics (measure of DNA variation), transcriptomics (assessment of RNA expression), epigenomics (DNA alterations that influence RNA expression), proteomics (protein expression) and most recently metabolomics (metabolite levels).
These analyses help to generate hypotheses about disease mechanisms. In the context of asthma, however, they have also been used to identify biomarkers that identify specific disease phenotypes especially if current diagnostic techniques are not very helpful. One such phenotype includes aspirin-induced respiratory disease which has featured in one Clinical and Experimental Allergy paper. Ban and colleagues have used metabolomics profiling in both serum and urine to assess differences between patients who have aspirin-tolerant asthma compared to those with aspirin-exacerbated respiratory disease. 2 They found that serum levels of leukotrienes (LTE4) and the ratio of LTE4/prostaglandin (PGF2a) before and after an aspirin bronchoprovocation test were significantly higher in patients with aspirin-exacerbated respiratory disease.
An advantage of metabolic profiling is the ability to give signals in non-invasive samples, such as urine and breathe. Metabolic profiles are being increasingly assessed in exhaled breath to find biomarker signatures that may identify clinical phenotypes and predict of loss of asthma control. Exhaled breath volatile organic compounds (VOCs) were measured in patients with partly controlled asthma as part of a steroid withdrawal study. 3 Two techniques were used, DOI: 10.1111/cea.13318 eNose and gas chromatography/mass spectrometry (GC/MS). Unbiased analyses were applied to assess ability to predict loss of asthma control. Breath profiles analysed by eNose predicted loss of control in 95% of cases while GC/MS was accurate in prediction in between 68% and 77% of cases. Prediction of exacerbations and loss of control are a key component of asthma management, and these data suggest exhaled breath compounds should be pursued in future interventional studies to validate utility in a clinical setting.
The utility of an unbiased pathway-based association study was applied from a previous genomewide association study (GWAS) of asthma to identify novel asthma susceptibility genes by Barreto-Luis et al. 4 Significant biological pathways using a gene-set enrichment analysis from the GWAS were identified, and all tested SNPs on significant gene pathways were identified and those with a disproportionate number of nominal significant associations were prioritized.
Analyses revealed two biological processes that were significantly enriched including a known asthma susceptibility locus (encoding SMAD family member 3), but also a novel susceptibility locus near
Wnt signalling genes, which may be associated with fibrosis and airway remodelling, thus highlighting a potential novel mechanistic avenue and pathway to be interrogated in asthma.
One of the key components of asthma pathophysiology, in addition to airway inflammation, 5, 6 is airway structural change, or remod- long-acting beta agonists on goblet cell metaplasia and the mechanisms involved was investigated by Lachowicz-Scroggins and colleagues. 8 Corticosteroids alone inhibited IL-13-induced goblet cell metaplasia, and the addition of long-acting beta agonists had an additive effect of reduced goblet cell metaplasia and mucus secretion.
Given that mucous production is an important feature of obstructive airway disease, this may be an important therapeutic mechanism.
Another structural cell that is significantly altered in asthma is airway smooth muscle. The role of the inflammatory cytokine calpain (a family of calcium-dependent endopeptidases), which are important role in extra-cellular matrix remodelling, was investigated in airway smooth muscle remodelling by Rao et al. 9 Calpain was shown to mediate cytokine-induced collagen-I synthesis and proliferation of airway smooth muscle cells via the mTORC2/Akt signalling pathway in a murine model and thus shown to play a role in regulating airway smooth muscle remodelling in asthma.
The range of mechanistic studies undertaken and published in the journal is highlighted by the data from the manuscript by Low et al. 10 The difficulty of disentangling vocal cord dysfunction from true wheeze in patients with asthma remains a significant clinical challenge. However, it is likely that in many patients, they
are not completely distinct but overlap. The presence of paradoxical vocal cord movement (PVCM) and whether it is associated with airflow limitation or other disease characteristics of asthma were investigated. PVCM was quantified using dynamic 320-slice computerized tomography of the larynx. Approximately a quarter of all patients with asthma had evidence of PVCM, and this was more frequently associated with airflow limitation. This unexpected relationship highlights the relatively high prevalence of PVCM in asthma and the need to investigate mechanistic interactions between extrathoracic airway obstruction and lower airway obstruction in asthma.
Finally, Davies and colleagues have published some interesting data showing a clear inverse association between hospitalization rates for children with asthma and total hours of sunshine in England. 11 Is this related to vitamin D or socioeconomic factors?
| Asthma clinical phenotypes
We are increasingly understanding asthma phenotypes as reviewed by Just and colleagues. 12 An asthma phenotype, in which both diagnosis and management are challenging, is fungal sensitization.
Immunological and inflammatory diagnostic biomarkers were related to clinical features including lung function and CT scan structural pathology in adults with fungal allergy and asthma by Woolnough et al. 13 Unbiased cluster analyses revealed specific IgE sensitization to fungi, specifically thermotolerant fungi including Aspergillus fumigatus was associated with fixed airflow limitation; no relationship was seen with total serum IgE. This highlights the risk of lung damage from fungal allergy in all asthmatic patients with positive-specific IgE to filamentous fungi, not just those who meet the criteria for allergic bronchopulmonary aspergillosis (ABPA).
Disentangling asthma and chronic obstructive pulmonary disease (COPD) have increased in complexity with development of greater insights into the immunology. Cluster analysis in the hunt for more precise phenotypes has become more sophisticated in terms of factors used as discriminators for both asthma and COPD and for overlaps between them. In a study, Hiriai and colleagues looked at the usual factors plus mRNA for a variety of transcription factors; they found four clusters, COPD, asthma-COPD overlap, late-onset nonatopic asthma and early-onset atopic asthma. 14 Perhaps reassuringly the asthma-COPD overlap cluster showed an overlapping of asthma and COPD features with atopy, eosinophilia and raised IgE but with worse lung function and a history of smoking. Presumably the "acid"
test of this sort of increasingly sophisticated phenotype development will be treatments that target the appropriate immunological features.
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| Asthma clinical management
The importance of stepping down inhaled corticosteroid (ICS) treatment in asthma has long been recognized. The criteria and factors that might inform this process are less clear than have those for stepping up ICS treatment. Saito and colleagues have looked at some of these factors using a factor analysis approach. 15 Upper airway complications, psychiatric morbidity and poor adherence to ICS were examined for their effects on a step down programme. Perhaps unsurprisingly, poor adherence to ICS was the most strongly predictive of failure to step down followed by upper airway complications.
Interestingly, psychiatric factors did not lead to significant step down failure on its own but it did increase problems in conjunction with the other two factors. This study suggests that factors other than just the state of a patient's asthma should be considered and remedied before a ICS reduction is considered.
Bjerregaard and colleagues have studied stable adult asthmatics from a specialist outpatient clinic. 16 Participants with elevated sputum eosinophils or elevated FeNO were found to be at greater risk of future viral-induced asthma exacerbations. It is not clear if this is an interaction between virus and type 2 inflammatory markers or simply that any exacerbation will tend to be more severe in those with elevated markers. The authors argue that understanding these interactions will be important in personalizing future antibody treatments.
There has long been an interest in the question of corticosteroid resistance amongst patients with severe asthma. Sousa and colleagues have explored this amongst a group of moderate and severe asthmatics. 17 Following a two-week course of oral prednisolone, both groups experienced a similar degree of suppression of blood and airway eosinophilia and serum cytokines. Even in patients on high doses of inhaled steroids, many showed a suppressive eosinophil response. As would be expected oral corticosteroids increased airway and blood neutrophils but interestingly airway neutrophilia was greater amongst the more severe asthmatics suggesting that neutrophils in severe asthma are related to corticosteroids therapy.
Electronic medical records from 1.4-m adult patients in primary care have been analysed to compare co-morbidities in patients with active asthma defined by read code and recent prescribed therapy and those without. 18 Almost all of the 39 co-morbidities were significantly more common amongst those with active asthma. Many are not surprising, COPD, bronchiectasis, eczema, other are less easily explained, chronic pain, hypertension, irritable bowel syndrome.
Depression and anxiety were both more common as has been shown in many studies. Some of the co-morbidity may be related to more frequent primary care contact but, as the authors point out, it has implications for studies of new asthma treatments where many comorbidities are excluded and for patient management where some of these, especially depression and anxiety, may need to be managed.
In this clinical study, Jabbal and colleagues explore one possible mechanism by which tiotropium added to ICS/LABA combinations might reduce asthma exacerbations. 19 They explore the idea that LAMA's might reduce LABA-induced beta2 receptor down regulation by receptor cross-talk thereby reducing airway hyperresponsiveness. This turned out not to be the case, at least for mannitol airway hyper-responsiveness amongst mild/moderate asthmatics, suggesting that other mechanisms such as remodelling or anti-inflammatory effect of tiotropium may be responsible.
However, tiotropium is currently considered as an option for steps 4 and 5 of the Global Initiative for Asthma in poorly controlled asthma.
Asthma and psychological disorders seem to be closely associated. Chang and colleagues published data demonstrating an independent association among suicidal ideation, asthma and bronchial hyperresponsiveness in adolescents. 20 It is getting increasingly difficult to know which biological to use in severe asthma. Cabon and colleagues have undertaken a systematic review and indirect meta-analysis of anti-interleukin-5 (IL-5) therapies for severe asthma. 21 They found that all the IL-5 blockades have similar efficacies and similar adverse effects.
| Rhinitis
Many cross-sectional studies have found associations between reported damp mouldy environments and a variety of self-reported respiratory symptoms. In a study taken from the Swedish Galen study amongst 26 000 adults, these self-reported associations are again confirmed. 22 In addition, there were similar associations between dampness and chronic rhinosinusitis. Also, they reported some evidence for a dose-response relationship in terms of the number of positive dampness measures. The key question in these studies is the potential mechanism for these associations, assuming of course that they are indeed causal.
Many patients with chronic upper airway disease complain that alcohol worsens their symptoms. Derycke and colleagues surveyed 1281 subjects and then looked at inflammatory markers in a subset. 23 Alcohol-related problems were commonest with NSAID exacerbated respiratory disease then chronic rhinosinusitis with nasal polyps and less so with chronic rhinosinusitis patients without nasal polyps and allergic rhinitis. This was associated with significantly higher nasal levels of the eosinophilic biomarker ECP.
Pfaar and colleagues described the dose-response characteristics of a new Timothy grass pollen allergoid immunotherapy product in comparison with a 6-grass pollen allergoid. 24 Both had similar efficacies. There has been discussion about the appropriate end-point for trials. Vicaut and colleagues use data from five previous trials to compare end-points. 25 In each study, the Combined Score or Adjusted Symptom Score gave similar results.
Some novel interventions for allergic rhinitis have also been described in Clinical and Experimental Allergy. Ellis and colleagues described a beneficial effect of an intranasal TLR7 agonist (GSK2245035). 26 Meanwhile, Berrings and colleagues describe how probiotics-impregnated bedding covers reduced house dust mite allergic rhinitis symptoms although allergens levels were not altered. Low-osmolar non-ionic radiocontrast media are in common use in clinical practice. Kim and colleagues have looked at the rate of adverse reactions to these in one hospital. 30 Iopromide was associated with most immediate reactions (1.03%) followed by iopamidol (0.67%), iohexol (0.64%) and iobitridol (0.34%).
Mastocytosis is associated with a high prevalence of anaphylaxis.
Zanoni and colleagues have looked at rates of vaccine reactions in their mastocytosis clinic. 31 They saw very few reactions and only recommend extending the normal 15-minute observation period to 30 minutes along with training for parents in how to recognize and manage allergic reactions.
Finally, Stretz and colleagues looked at whether temporary omalizumab co-treatment with high maintenance venom dose can prevent recurrent systemic allergic reactions with venom immunotherapy. 32 Their retrospective, observational case series with 10 patients on combination therapy and five just on immunotherapy suggested that a short course of omalizumab is very helpful in this group.
| Food allergy
We now have a much better understanding about how childhood food allergy develops. The review by Foong and Brough nicely summarizes this. 33 We also have an improving understanding of the allergens that induce allergy reactions to foods as exemplified by Sharp and colleagues review on fish allergens. 34 It also seems that there are specific patterns or phenotypes of food allergy. 35 Finally, Stensgaard and colleague have demonstrated the major impact that food allergy has on the whole family. 36 Diagnosing food allergy remains a challenge with food provocation challenges frequently being required. van der Valk and colleagues have described, in a prospective study, how specific IgE to components Ana o 1, 2 and 3 can be used to diagnosis children with suspected cashew nut allergy. 37 Another approach, which is become more established, is the basophil activation test which Santos and
Shreffler reviewed. 38 There are some novel approaches, and Lindvik and colleague published data from 81 children demonstrating that conjunctival provocation testing has a sensitivity and the specificity of 0.96 and 0.83, respectively, for peanut allergy. 39 None had a severe adverse reaction with this approach where as a quarter had an anaphylactic reaction with the food challenge.
We are still working on effective therapies for food allergies. A popular approach is to initiate patients with cow's milk or egg allergy on baked milk or baked egg, respectively. 40 Unfortunately, there seems to be limit evidence to suggest that this approach speeds up outgrowth although it may simplify meals times for families. 41 A potential treatment strategy is omalizumab, and Vetander and colleagues publish data to suggest that an individualized dosing can prevent reactions in patients with food allergy. 42 Specific immunotherapy is another option although serious adverse events are not infrequent. 43 An alternative route is to utilize an allergen that has been processed to reduce its allergenicity without reducing its immunogenicity. Tao has described how boiled peanuts are associated with less reactions than expected in an observational cases series of children undergoing peanut oral allergen immunotherapy (OIT). 44 Promising but needs to be tested against conventional OIT protocols. Finally, the psychological issues associated with food allergy need to be addressed. Boyle and colleagues have published a randomized controlled trial looking at a brief psychological intervention for food allergy. 45 They found that anxiety could be reduced in mother with moderate/high anxiety at enrolment.
| Eczema
Perhaps the most convincing evidence for the preventative impact of probiotics is for eczema. Peldan and colleagues have followed their randomized control trial participants to 10 years of age. Perinatal probiotics were still associated with reduced eczema at 10 years. 46 However, they were also associated with increased aller- Also, Wang and colleagues have looked at the proteomic signature associated with eczema. 47 They found unique proteomic signatures in the serum which appear to potential distinguish different inflammatory skin diseases. The authors suggest that this approach might provide an insight into disease pathogenesis, diagnosis and novel therapies.
| EPIDEMIOLOGY

| Early risk factor for atopic disease
The interest in early risk factors for subsequent asthma, rhinitis and eczema with a special focus towards the hygiene hypothesis and microbiota has been displayed in several publications in 2017. In a Finnish study, significant differences were found in allergy prevalence between young people from Finnish and Russian Karelia. 48 Skin microbiota, as well as bacterial and fungal communities in nasal ROBERTS ET AL.
| 1609 mucosa, was also contrastingly different between the populations, and diversity of Actinobacteria was clearly associated with reduced allergy in Russia. Early exposure to dogs has been reported to decreases the risk of asthma, 49, 50 and Wegienka et al have now proposed that there are subgroup differences (race, gender and delivery mode) in the association. 51 Laboratory animals do not offer a similar protection towards asthma and allergic disease. Simoneti and colleagues have reported in Clinical and Experimental Allergy that allergic sensitization to laboratory animals is more associated with asthma, rhinitis and skin symptoms than sensitization to common allergens. 52 Exposure to antibiotics in fetal life does not seem to increase the risk of asthma after taking family confounding such as genes and shared environmental factors into account 53 or using paternal exposure as negative control. 54 Timm and colleagues though report an association between prenatal exposure to antibiotics and increased risk of atopic dermatitis (AD) in the first 18 months of life among children born to atopic mothers. 55 Travelling is another risk factor that may be associated with microbiota and also with socioeconomic status. Results from GINIplus and LISAplus show that early life travelling does not increase the risk of atopic outcomes until 15 years of age. 56 Nevertheless, there is a need to carefully interpret potential causal effects and to take genetic and environmental confounding as well as residual confounding into account. We look forward to future studies using family design and other innovative methods.
57,58
| Nutritional influences
Infant feeding patterns 59 as well as dietary antioxidant 60, 61 and subsequent allergic disease have also been in focus in 2017 Clinical and Experimental Allergy, along with risks of asthma in overweight children. 62 Two interesting articles have focused on maternal distress or psychiatric symptoms before and during pregnancy, and later risk of childhood eczema or atopic disease. 63, 64 In the Southampton Women's Survey, an association was found between maternal stress before pregnancy and offspring risk of eczema at 12 months. There was also somewhat increased risk of offspring eczema among mothers with symptoms postnatally but not after taking account of preconception stress. 65 These findings confirm the importance to address critical exposure periods or cumulative exposure to maternal distress over pregnancy 66 and also point to potentially modifiable influences. The other study, from the Generation R, found that maternal psychiatric symptoms during pregnancy were associated with increased risks of childhood inhalant allergy and eczema, independent of symptoms after delivery. 64 They also adjusted their finding for paternal psychiatric symptoms which highlights the importance of using fathers as negative control. 
| Other epidemiological highlights
Finally, Clinical and Experimental Allergy has also included reports on sensitization patterns for rhinitis and asthma multimorbidity from the EGEA study, 67 an association between DNA methylation of Th2 The antigen-specific CD4+ Th2 T cell response is thought to be mediated by DC presentation of pollen allergens to naïve CD4+ T cells in the draining lymph nodes. 70, 73 Critical steps for the DC- induced TIM4 expression and that the induction of TIM4 on DC cells was specific to Der f8 as stimulation of DCs with a Derf8-deficient dust mite extract (DME) did not stimulate TIM4 expression in
BMDCs. Employing an in vivo model, the authors show that exposure of mice to Derf8 or DME and not Der f8-deficient DME led to the induction of allergic airway disease (AAD) in mice including expansion of CD4+ cells, increased systemic Th2 cytokines, Derf8-specific IgE and pulmonary inflammation (eosinophils, neutrophils and macrophages). Notably, the pulmonary allergic response was inhibited by anti-TIM4 mAb treatment suggesting that Derf8-driven allergic inflammatory phenotype was dependent on TIM4 activity.
Intriguingly, treatment of DME-allergic mice with Derf8-deficient DME-specific immunotherapy (SIT) reduced the pulmonary allergic response and that this was associated with the development of antigen-specific CD4+ CD25+ FoxP3+ T regulatory (Treg) cells in the lung. In support of an important role for TIM4 in the development of CD4+ Th2 cell differentiation, previous studies by Lee et al have demonstrated using a DC: CD4 T cell co-culture system that blockade of TIM4 on DC's significantly inhibits Th2 cell differentiation and facilitated the induction of CD4+ T reg cell expansion. 76 The molecular action of how glutathione S transferases (GST) pro- 103 Given the demonstration that ANO1 may be a key regulator for hypersecretory diseases such as asthma and GC hyperplasia and mucus secretion, this would make them an attractive candidate for asthma therapeutics.
| The impact of allergic comorbidities on allergic phenotypes
Epidemiological reports indicate an association between food sensitization and increased risk for the development of allergic diseases, in particular asthma. [104] [105] [106] [107] Furthermore, it is well-established that asthma is a comorbidity for the development of severe food anaphylactic reactions. [108] [109] [110] Utsch and colleagues employing an experimental model to peanut (PN)-induced food allergy examined the impact of food sensitization on aeroallergen (HDM) sensitization and the development of asthmatic phenotype. 111 The authors show that prior sensitization to PN enhanced HDM-induced Th2 responses in the lung. Surprisingly, the increased CD4+ Th2 cytokine response was not associated with enhancement of HDM-induced asthma manifestations such as pulmonary eosinophilic inflammation, mucus hypersecretion and AHR.
Given the previous demonstrations that CD4+ Th2 cells and ILC2 cells are important in the augmentation of the food allergic response, it would suggest that the pre-existing peanut food allergic response provides an unspecific bystander activation for the HDM-sensitization leading to increased Type II cytokine production. 112 Intriguingly, the HDM-induced airway inflammation while enhancing the mast cell response did not seem to impact the anaphylactic response to PN.
However, the lack of effect of HDM-sensitization on exacerbation of the PN-induced anaphylactic reaction may relate to the induction of both a IgG1-basophil/macrophage and IgE-MC-dependent responses 113 following systemic antigen challenge and potential masking of any differences in the IgE-mediated induced clinical symptoms.
| Inhibiting airway inflammation and remodelling
A major histopathologic manifestation of asthma is the onset of airway remodelling, which is thought to contribute to the irreversible, or partially reversible, airflow obstruction and ultimately unresponsiveness to asthma therapies such as corticosteroids. [114] [115] [116] Recently, there has been advancement in the utilization of mesenchymal stem cells (MSCs) in the treatment of pulmonary disease phenotypes. 
| Food allergy and anaphylaxis
| Oral tolerance
As food allergy has become a major public health concern, there has been increasing interest in the understanding of the immunological processes that regulate oral tolerance versus sensitization. 124 In nonfood allergic individuals, food antigens promote immune tolerance associated with the expansion of FoxP3+ TR cells and also IL-10 or IFNγ-secreting TR1 cells. 125 In food allergic individuals, exposure to innocuous dietary antigens leads to an inappropriate CD4+ Th2 response associated with pro-Type II cytokine production (IL-4, IL-5, IL-9, IL-13) ILC2 response which leads to priming of the basophils and mast cells and development of food-specific IgE. 124, 125 Currently, the behavioural and environmental determinants that favour oral immune tolerance vs sensitization to foods are not fully understood. Recent clinical evidence suggests that early introduction of solid foods in the diet such as egg and peanut can be beneficial and promote food tolerance. [126] [127] [128] [129] Furthermore, introduction of solid foods while continuing breastfeeding is also thought to enhance tolerance induction and prevention of food allergy possibly through the presence of immunomodulatory factors such as TGFβ in breastmilk. 130 Rekima and colleagues examined a birth cohort that consisted of mother-child pairs from the French EDEN birth study and surprisingly detected egg antigen (OVA)-specific IgG and IgA in breastmilk from allergic and not allergic mothers. 131 While OVA-specific IgA levels in mother milk from allergic and non-allergic mothers were similar, the level of OVA-specific IgG was found to be significantly higher in milk from allergic mothers compared with non-allergic mothers. These clinical observations prompted the question of whether oral antigen exposure through breastmilk could prevent food allergy in young offspring the investigators employed a mouse model of food allergy. 99 The author shows that mice breastfed from OVA-sensitized mothers who were exposed to OVA during lactation had decreased food allergy susceptibility at 6 weeks of age. Notably the protective effects were temporary as food allergen exposure to breastfed pups at 13 weeks of age-induced food allergy. In efforts to prolong the breastfeeding-mediated suppressive effects, the authors administered and claudin-4 via the SMAD-signalling axis. 132, 133 Recently, there has been increasing reports of food allergic reactions to food additives. 134, 135 In Denmark, it is reported that a prevalence of 1%-2% of children and about 1% of adults have had an adverse reaction to food additives. 135 Food additives are defined as substances added to food at any stage of production, processing, treatment packaging or storage, and there are currently greater than 3000 substances approved for use as food additives by the US Food Drug Administration. Yamashita and colleagues evaluated the ability of artificial sweeteners and mixtures of food additives to break oral tolerance and induce food allergy in mice. 136 The authors assessed a number of sweeteners (acesulfame potassium, aspartame, xylitol and meso-erythritol), moisture absorber (silicon dioxide), natural sugars Clinical study performed in rural alpine area of Switzerland has revealed that children raised on farms have less allergies than children living in the same area but not on a farm. 142 This was supported by a cross-sectional study including farmers and non-farmers children from Austria, Germany and Switzerland that revealed the protective farming effect where the presence of cattle and other animals provided a strongly protective environment against atopy in young children. 143 A limitation to our understanding of the molecular mechanisms involved in the driving the protective farming effect is the lack of appropriate animal model systems. To begin to address, Frossard and colleagues developed a mouse model system that mimics the farm versus nonfarm (University animal facility) environments to assess the influence of microbial environment on allergy susceptibility. 144 The authors 
| Immunotherapy
In other work, circulating invariant natural killer T cells (iNKTs) were assessed in the blood of children who received oral immunotherapy (OIT) for cow milk allergy (CMA). 158 These cells, which respond to lipid antigens, had previously been shown by the investigators to be lower in CMA. In the present study, increased numbers of iNKTs were associated with OIT, along with a switch in cytokine profile from Th2 to Th1. Notably, children were able to reintroduce milk in their diet after OIT and increased iNKTs persisted for several months after completion of the OIT regimen. These results warrant further examination of iNKTs in allergen desensitization to foods. While such DNA traps (NETs) can capture microbes, work by Pham and colleagues in the journal points to a pro-inflammatory role in asthma. 160 Peripheral blood neutrophils from patients with severe asthma that were stimulated with IL-8 displayed enhanced autophagy and NET levels compared with cells from patients with less severe disease. Notably, higher NET levels were linked to worse lung function, and the ability to mediate epithelial damage and mediator release from eosinophils in functional assays, thereby supporting a pathogenic role.
Two papers focused on metabolites in exhaled breath as markers of disease processes in the asthmatic airways. Kowal et al reported increased levels of a variety of arachidonic acid metabolites in patients experiencing bronchoconstriction after bronchial challenge with dust mite extract. 161 These included the potent eosinophil chemoattractant 5-oxo-eicosatetraenoic acid (5-oxo-ETE), which is a product of the 5-lipoxygenase pathway that also results in leukotriene synthesis. Levels of 5-oxo-ETE were markedly higher than other 5-lipoxygenase metabolites, including leukotriene D4, suggesting an important role in asthma pathogenesis. The second paper conducted a systematic review of 27 studies to assess the diagnostic accuracy of the fraction of NO in exhaled breath. 162 This test, which can be performed using a hand-held monitor, may provide an indicator of eosinophilic inflammation of the airways. Diagnostic accuracy was found to be highly variable, and the results imply that more work is needed using well-designed studies to determine the suitability of this test within the asthma diagnosis pathway.
| Rhinitis allergic mechanisms
Other work pointed to an adverse effect of seasonal allergic rhinitis on cognitive functions related to memory and multitasking. 163 This study highlighted the knowledge gap regarding the actions of various inflammatory mediators of allergic disease on the central nervous system.
| Systemic mastocytosis
Gulen et al addressed whether elevated levels of mast cell mediators in systemic mastocytosis derive from increased numbers of tissue mast cells or their increased activation status at the single-cell level. 164 Assessment of the responsiveness of skin and airway mast cells both in vitro and in vivo was found to be similar in the face of increased numbers in blood and urine. The authors proposed that leakage of mediators from cells explains the high levels of mast cell mediators in systemic mastocytosis, but acknowledged that more work is needed to understand the episodic symptoms in this disease.
| ALLER GE NS
| House dust mite
In Clinical and Experimental Allergy in 2017, Oseroff and colleagues have analysed the house dust mite (HDM)-derived protein targets of T cell responses in individuals with HDM allergy. 165 They used a mass spectrometry proteomic approach finding 29 known allergens and 61 novel proteins. T cell reactivity was seen to a large number of T cell epitopes-15 antigens dominated the response with most being novel. Most of the known allergens were also IgE reactive but few of the novel ones were IgE reactive. This will provide lots of new targets for diagnostics and immunotherapeutics for HDM allergy.
| Pollens
The current European Union regulatory framework controlling allergen products distinguishes between relevant and non-relevant allergens. Minor allergens are usually not controlled by these regulations. Zimmer and colleagues have looked at three minor birch pollen allergens (Bet v 4, Bet v 6, Bet v 7) in 70 different products using an ELIZA system. 166 They found large differences within and between products in minor allergen content with no relationship with major allergen content. Does this variability impact on characteristics as diagnostic tools or therapies?
Smiljanic and colleagues have looked at the allergome of the ragweed subpollen particles which can be inspired into the lower airway. 167 These are generated when ragweed is hydrated or exposed to a thunder storm. The subpollen particles contained large amounts of the minor Amb a 4 and major Amb a 1 allergens. This suggests that this is important in ragweed allergy.
Specific IgG4 levels increase with allergen immunotherapy, and this is thought to be one of mechanisms by which it minimizes clinical allergy. Groh and colleagues described how they assessed whether birch pollen immunotherapy generates Bet v 1a IgG4 that compete with IgE for identical epitopes or whether it has novel epitopes. 168 They concluded that patients receiving allergen immunotherapy develop Bet v 1a-specific IgG4 which competes with IgE for partly identical or largely overlapping epitopes.
| Cockroach
In 2017 Clinical and Experimental Allergy, Mindaye and colleagues described how liquid chromatography and multiple reaction monitoring mass spectrometry can be used to quantify five German cockroach allergens (Bla g 1, Bla g 2,Bla g 3, Bla g 4 and Bla g 5). 169 Meanwhile, Polley and colleagues described how they looked for trypsin-like proteinases in German cockroach allergen extracts. 170 Proteinases contribute to allergenicity and airway inflammation by activating proteinase-activated receptors. They used a trypsin-specific activity-based probe to detected proteins that were then isolated using ion-exchange chromatography. Three serine proteinases were isolated which showed some homology to Per a 10. The authors speculate that they may be important in allergen sensitization and may represent therapeutic targets.
| Jack Jumper ant venom
Allergy to Jack Jumper ant venom is important in some areas, such as Australia. Wanandy and colleagues described how they assessed the consistency of allergenic material and the impact of environmental factors. 171 They found good batch to batch consistency but degradation above 40°C. This is important to maintain the diagnostic utility of skin prick testing reagents and efficacy of immunotherapy product.
| Precautionary allergen labelling
Zurzolo and colleagues have looked at how widely the Australian food industry is using the VITAL approach to making rational decisions on precautionary allergen labelling. 172 A total of 59 manufacturers completed the questionnaire. They reported that a quarter of products had been through the VITAL risk assessment process but had no PAL statement on the label. They suggested that it might be helpful if such foods had a permissive "safe to eat" label.
| CONCLUSION S
The year 2017 has provided further advances in the field of allergy.
We look forward to publish more interesting observations in 2019.
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